However, when using LTβR agonists, more ICC-like tumors were observed in AKT/β-catenin mouse model, suggesting LTβR signaling skews AKT/β-catenin pathology towards a more ICC-like phenotype29. Here, LTBR is linked to intrahepatic cholangiocarcinoma.